Literature DB >> 17145878

A small interfering CD147-targeting RNA inhibited the proliferation, invasiveness, and metastatic activity of malignant melanoma.

Xiang Chen1, Jing Lin, Takuro Kanekura, Juan Su, Wei Lin, Hongfu Xie, Yixi Wu, Juan Li, Mingliang Chen, Jing Chang.   

Abstract

CD147 plays a critical role in the invasive and metastatic activity of malignant melanoma cells by stimulating the surrounding fibroblasts to express matrix metalloproteinases and vascular endothelial growth factor. We developed a system that blocks CD147 in the human malignant melanoma cell line, A375, using RNA interference. By transfecting melanoma cells with the small interfering RNA (siRNA) that targets human CD147, we were able to establish two stable clones in which CD147 expression was significantly down-regulated. This resulted in the decreased proliferation and invasion of A375 cells in vitro. CD147 siRNA also down-regulated the expression of vascular endothelial growth factor in these cells and reduced the migration of vascular endothelial cells. The reduction in the CD147 level suppressed the size of s.c. tumors and the microvessel density in an A375 s.c. nude mouse xenograft model. In addition, the in vivo metastatic potential of A375 cells transfected with CD147 siRNA was suppressed in a nude mouse model of pulmonary metastasis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17145878     DOI: 10.1158/0008-5472.CAN-06-1536

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  53 in total

1.  Ratio of miR-196s to HOXC8 messenger RNA correlates with breast cancer cell migration and metastasis.

Authors:  Yong Li; Maoxiang Zhang; Huijun Chen; Zheng Dong; Vadivel Ganapathy; Muthusamy Thangaraju; Shuang Huang
Journal:  Cancer Res       Date:  2010-08-24       Impact factor: 12.701

2.  CD147 overexpression is a prognostic factor and a potential therapeutic target in bladder cancer.

Authors:  Yi-Jun Xue; Qiang Lu; Zhi-Xi Sun
Journal:  Med Oncol       Date:  2010-05-28       Impact factor: 3.064

3.  Basigin/CD147 promotes renal fibrosis after unilateral ureteral obstruction.

Authors:  Noritoshi Kato; Tomoki Kosugi; Waichi Sato; Takuji Ishimoto; Hiroshi Kojima; Yuka Sato; Kazuma Sakamoto; Shoichi Maruyama; Yukio Yuzawa; Seiichi Matsuo; Kenji Kadomatsu
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

4.  Expression of HAb18G in non-small lung cancer and characterization of activation, migration, proliferation, and apoptosis in A549 cells following siRNA-induced downregulation of HAb18G.

Authors:  Xiaoyan Xu; Shuguang Liu; Bin Lei; Wenxia Li; Ni Lin; Wenjie Sheng; Aili Huang; Hong Shen
Journal:  Mol Cell Biochem       Date:  2013-09-08       Impact factor: 3.396

5.  Interaction of monocarboxylate transporter 4 with beta1-integrin and its role in cell migration.

Authors:  Shannon M Gallagher; John J Castorino; Nancy J Philp
Journal:  Am J Physiol Cell Physiol       Date:  2008-12-10       Impact factor: 4.249

6.  EMMPRIN expression is required for response to bevacizumab therapy in HNSCC xenografts.

Authors:  J Robert Newman; Emily E Helman; Seena Safavy; Wenyue Zhang; Eben L Rosenthal
Journal:  Cancer Lett       Date:  2008-11-05       Impact factor: 8.679

7.  A highly bone marrow metastatic murine breast cancer model established through in vivo selection exhibits enhanced anchorage-independent growth and cell migration mediated by ICAM-1.

Authors:  Munehisa Takahashi; Mutsuo Furihata; Nobuyoshi Akimitsu; Morihiro Watanabe; Sunil Kaul; Noboru Yumoto; Tomoko Okada
Journal:  Clin Exp Metastasis       Date:  2008-03-14       Impact factor: 5.150

Review 8.  Cyclophilin-CD147 interactions: a new target for anti-inflammatory therapeutics.

Authors:  V Yurchenko; S Constant; E Eisenmesser; M Bukrinsky
Journal:  Clin Exp Immunol       Date:  2010-03-16       Impact factor: 4.330

9.  RNAi-mediated silencing of CD147 inhibits tumor cell proliferation, invasion and increases chemosensitivity to cisplatin in SGC7901 cells in vitro.

Authors:  Bo Wang; Yong-Fei Xu; Bang-Shun He; Yu-Qin Pan; Li-Rong Zhang; Chan Zhu; Li-Li Qu; Shu-Kui Wang
Journal:  J Exp Clin Cancer Res       Date:  2010-06-03

10.  EMMPRIN promotes melanoma cells malignant properties through a HIF-2alpha mediated up-regulation of VEGF-receptor-2.

Authors:  Faten Bougatef; Suzanne Menashi; Farah Khayati; Benyoussef Naïmi; Raphaël Porcher; Marie-Pierre Podgorniak; Guy Millot; Anne Janin; Fabien Calvo; Céleste Lebbé; Samia Mourah
Journal:  PLoS One       Date:  2010-08-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.